Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts Fulltext Access 11 Pages 2006
Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia Fulltext Access 11 Pages 2006
Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice Fulltext Access 11 Pages 2006
Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia–ischemia Fulltext Access 11 Pages 2006
Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody Fulltext Access 11 Pages 2006
Breakdown of the blood brain barrier and blood–cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC Fulltext Access 11 Pages 2006
Hypothalamus–pituitary–adrenal axis during Trypanosoma cruzi acute infection in mice Fulltext Access 11 Pages 2006
Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis Fulltext Access 11 Pages 2006
Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages Fulltext Access 11 Pages 2006
In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids Fulltext Access 11 Pages 2006
Expression and distribution of Toll‐like receptors in the brain during murine neurocysticercosis Fulltext Access 11 Pages 2006
The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2 Fulltext Access 11 Pages 2006
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes Fulltext Access 11 Pages 2006
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein Fulltext Access 11 Pages 2006
Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge Fulltext Access 11 Pages 2006
Antibody response to influenza vaccination in the elderly: A quantitative review Fulltext Access 11 Pages 2006
Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis Fulltext Access 11 Pages 2006
Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates Fulltext Access 11 Pages 2006
Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells Fulltext Access 11 Pages 2006
Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis Fulltext Access 11 Pages 2006
Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates Fulltext Access 11 Pages 2006
DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity Fulltext Access 11 Pages 2006
Immunization with fibrillar Aβ1–42 in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Aβ Fulltext Access 11 Pages 2006
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects Fulltext Access 11 Pages 2006
A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine Fulltext Access 11 Pages 2006
Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library Fulltext Access 11 Pages 2006
Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis Fulltext Access 11 Pages 2006
Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities Fulltext Access 11 Pages 2006
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report Fulltext Access 11 Pages 2006
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study Fulltext Access 11 Pages 2006
Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma Fulltext Access 11 Pages 2006
Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes Fulltext Access 11 Pages 2006
Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFα in the cutaneous microvasculature Fulltext Access 11 Pages 2006
Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK) Fulltext Access 11 Pages 2006
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease Fulltext Access 11 Pages 2006
G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: A possible mechanism for exacerbation of multiple sclerosis Fulltext Access 11 Pages 2006
Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA Fulltext Access 11 Pages 2006
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis Fulltext Access 11 Pages 2006
Intravenous immunoglobulin suppresses experimental myasthenia gravis: Immunological mechanisms Fulltext Access 11 Pages 2006
Peroxisome proliferator-activated receptor-α and retinoid X receptor agonists inhibit inflammatory responses of astrocytes Fulltext Access 11 Pages 2006
Genetic evidence for the involvement of Fcγ receptor III in experimental autoimmune myasthenia gravis pathogenesis Fulltext Access 11 Pages 2006
T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients Fulltext Access 11 Pages 2006
Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures Fulltext Access 11 Pages 2006
The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells Fulltext Access 11 Pages 2006
The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: Implications for multiple sclerosis Fulltext Access 11 Pages 2006
Phenotypic characterization of autoreactive T cells in multiple sclerosis Fulltext Access 11 Pages 2006
PPARγ antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-Deoxy-Δ12,14-Prostaglandin J2 Fulltext Access 11 Pages 2006
CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis Fulltext Access 11 Pages 2006
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses Fulltext Access 11 Pages 2006
Uneven distribution of MHC class II epitopes within the influenza virus Fulltext Access 11 Pages 2006
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha Fulltext Access 11 Pages 2006
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques Fulltext Access 11 Pages 2006
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits Fulltext Access 11 Pages 2006
DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses Fulltext Access 11 Pages 2006
Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain Fulltext Access 11 Pages 2006
Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli Fulltext Access 11 Pages 2006
Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens Fulltext Access 11 Pages 2006
Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial Fulltext Access 11 Pages 2006
Potential cost-effectiveness of annual influenza immunization for infants and toddlers: Experience from Canada Fulltext Access 11 Pages 2006
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally Fulltext Access 11 Pages 2006
Immunization by particle bombardment of antigen-loaded poly-(dl-lactide-co-glycolide) microspheres in mice Fulltext Access 11 Pages 2006
Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice Fulltext Access 11 Pages 2006
Female genital tract immunization: Evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation Fulltext Access 11 Pages 2006
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge Fulltext Access 11 Pages 2006
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-β without concomitant T cell responses Fulltext Access 11 Pages 2006
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence Fulltext Access 11 Pages 2006
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys Fulltext Access 11 Pages 2006
Immunization with Neisseriameningitidis outer membrane vesicles prevents bacteremia in neonatal mice Fulltext Access 11 Pages 2006
Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection Fulltext Access 11 Pages 2006
Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection Fulltext Access 11 Pages 2006
Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: A potential approach for local delivery of cytokines during vaccination Fulltext Access 11 Pages 2006
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine Fulltext Access 11 Pages 2006
Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy Fulltext Access 11 Pages 2006
Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery Fulltext Access 11 Pages 2006
Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines Fulltext Access 11 Pages 2006
Zebrafish (Danio rerio) as a model for the study of vaccination against viral haemorrhagic septicemia virus (VHSV) Fulltext Access 11 Pages 2006
Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani Fulltext Access 11 Pages 2006
A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II Fulltext Access 11 Pages 2006
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP) Fulltext Access 11 Pages 2006
Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro Fulltext Access 11 Pages 2006
Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin Fulltext Access 11 Pages 2006
In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV Fulltext Access 11 Pages 2006
A comparative immunopathological study of injection site reactions in salmonids following intraperitoneal injection with oil-adjuvanted vaccines Fulltext Access 11 Pages 2006
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China Fulltext Access 11 Pages 2006
Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis Fulltext Access 11 Pages 2006
The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection Fulltext Access 11 Pages 2006
Mucosal immunization against hepatitis A: Antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid Fulltext Access 11 Pages 2006
The effect of co-administration of DNA carrying chicken interferon-γ gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination Fulltext Access 11 Pages 2006
Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited Fulltext Access 11 Pages 2006
Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults Fulltext Access 11 Pages 2006
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects ≥13 years of age Fulltext Access 11 Pages 2006
Single epitope mucosal vaccine delivered via immuno-stimulating complexes induces low level of immunity against simian-HIV Fulltext Access 11 Pages 2006
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries Fulltext Access 11 Pages 2006
IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors Fulltext Access 11 Pages 2006
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials Fulltext Access 11 Pages 2006
The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep Fulltext Access 11 Pages 2006